Why I Think the Industry Gets Vitamin C Stability All Wrong

What Most Brands Mean When They Say "Stable" — And Why It's Wrong

If you've spent any time researching vitamin C serum stability formulation science, you've almost certainly encountered the word "stable" used as though it's a binary property — something a formula either has or doesn't have. That framing is scientifically incoherent, and I think it does real harm to consumers trying to make informed purchasing decisions.

Stability is not a yes-or-no condition. It is a kinetic description of how quickly a molecule degrades under a specific set of conditions over a defined time window. When a brand says their formula is "stabilized," the scientifically meaningful follow-up questions are: Stable at what temperature? Stable after how many freeze-thaw cycles? Stable with what oxygen headspace? Stable at what measured pH? If there are no answers to those questions — and in my experience reading competitor literature, there rarely are — then "stable" is a marketing claim, not a scientific one.

In my lab, stability is framed as a problem with at least five simultaneous variables: pH, dissolved oxygen, temperature, light exposure, and container design. These variables don't operate independently. A formula that performs well at low pH can still degrade rapidly if the container allows UV transmission. A formula with an excellent pump mechanism can still oxidize if it's stored in a warm bathroom. The consumer is part of the stability equation, and almost no brand communication accounts for that honestly.

The Real Enemy Isn't Oxidation — It's the Formulation Conditions That Accelerate It

Here's something that pharmaceutical sciences training makes immediately obvious but that consumer-facing skincare content almost never states clearly: oxidation of L-ascorbic acid is inevitable. You cannot prevent it. The formulator's job is to slow the reaction rate to the point where the product remains effective within its intended use window. That is a fundamentally different goal than elimination, and conflating the two leads to poor formulation decisions.

One of those poor decisions, in my view, is the widespread adoption of ferulic acid as a "stability booster." I have never used ferulic acid in a Phyto-C formula, and I want to be direct about why. Lee et al. (2005, Archives of Pharmacal Research) demonstrated that ferulic acid can drive NADPH oxidase-mediated reactive oxygen species generation under certain conditions. That is a pro-oxidant signal in the literature that I take seriously. The industry has largely built its ferulic acid narrative around the SkinCeuticals-adjacent research, and I understand why — those papers are compelling. But I am not comfortable introducing an ingredient with a documented pro-oxidant mechanism into a formula built around antioxidant protection. That is a risk I've chosen not to take, and I stand by that position even though it puts me in the minority.

What Pharmaceutical Sciences Actually Teaches About Antioxidant Degradation

My PhD in pharmaceutical sciences trained me to treat L-ascorbic acid the way a pharmacognosist treats any bioactive compound: as a molecule with defined degradation kinetics, not as a cosmetic texture ingredient. That framing matters because pharmaceutical stability science is governed by ICH Q1A guidelines — a rigorous, internationally recognized framework that defines real-condition and accelerated stability testing protocols. Cosmetic stability testing has no equivalent mandatory standard, which is why the industry's self-reported "stability" claims are so inconsistently defined.

Ascorbic acid degrades through two primary pathways. The first is aerobic degradation: oxygen-dependent oxidation that produces dehydroascorbic acid and eventually diketogulonic acid, which is the irreversibly inactive form. Most skincare stability content stops here. The second pathway is anaerobic degradation, which is driven by pH fluctuation and, critically, by trace metal ion catalysis. Even at low pH — which the aerobic pathway literature correctly identifies as protective — the presence of trace copper or iron ions dramatically accelerates ascorbic acid degradation through Fenton-like chemistry. This is a factor that is almost never discussed publicly by formulators, and I think it's one of the most important variables in the stability calculation.

Trace metals enter formulas through water, through raw material impurities, and through contact with metal manufacturing equipment. If you're not actively chelating them out of the formulation environment, you have a degradation accelerant built into your formula regardless of how tightly you've controlled your pH.

How I Actually Approach Stability in the Phyto-C Formulas I've Built

I won't disclose proprietary process specifics, but I can describe the strategic logic behind how I approach L-ascorbic acid stability in my formulations.

First, I use bioflavonoids as a synergistic antioxidant network. This is not arbitrary. Bioflavonoids serve two simultaneous functions that are directly relevant to both degradation pathways I described above. They participate in the regeneration of oxidized ascorbic acid — essentially recycling the molecule back to its active form — and they act as natural chelating agents for trace metal ions, addressing the anaerobic degradation risk that most formulations leave unmanaged. This is why I've consistently chosen bioflavonoids over ferulic acid: the mechanism is cleaner, the risk profile is better understood in the context of my specific formulation goals, and the dual-pathway coverage is scientifically more defensible.

Second, I treat container selection as a formulation variable, not a packaging afterthought. Oxygen headspace, UV transmittance, and the mechanics of the dispensing system — pump versus dropper versus tube — all affect the stability calculation before I finalize a formula. A dropper bottle that admits air with every use is a different stability environment than a well-designed airless pump. I factor this in during formulation development, not after.

Third, concentration matters more than most people realize. I formulate at 20% L-ascorbic acid in my E in C Advanced. At that concentration, the buffering capacity of the solution itself helps maintain the protective acidic environment the molecule needs. A lower-concentration formula doesn't have that buffering advantage to the same degree, which means it is more dependent on external pH management and less inherently self-protective.

Frequently Asked Questions

If a vitamin C serum turns yellow, is it already degraded and useless?

In my view, yellowing is a signal worth taking seriously, but it's not a binary degradation endpoint. Early yellowing reflects dehydroascorbic acid accumulation — a partially reversible oxidation state. Amber or brown color indicates the formation of diketogulonic acid and other irreversible breakdown products, at which point the antioxidant activity of the ascorbic acid is substantially compromised. I tell people: don't wait for brown. Yellow is a prompt to use the product faster or store it more carefully.

Does refrigerating vitamin C serum actually slow oxidation in a meaningful way?

Yes, meaningfully. Temperature is one of the primary kinetic variables in ascorbic acid degradation. Reducing storage temperature from 25°C to 4°C slows the reaction rate in a way that is pharmacokinetically significant. From my experience, refrigeration is one of the highest-impact steps a consumer can take without changing the formula itself. It won't stop degradation, but it extends the effective use window considerably.

Why do you use bioflavonoids instead of ferulic acid if both are described as antioxidant stabilizers?

Because I read the full literature, not just the most-cited papers. Lee et al. (2005) documented NADPH oxidase-mediated ROS generation associated with ferulic acid — a pro-oxidant mechanism that conflicts with the goals of an antioxidant stabilization strategy. Bioflavonoids offer chelation activity against trace metal ions alongside antioxidant regeneration, covering both degradation pathways without that documented pro-oxidant risk. That's the formulation logic, and I've held to it across every Phyto-C product I've built.

Is a lower pH always better for vitamin C serum stability?

Lower pH is protective against aerobic oxidation, but it's not a complete answer. As I described, anaerobic degradation driven by trace metal ions can proceed even at low pH. Additionally, very low pH formulas — below 2.5 — introduce tolerability concerns that create a real-world compliance problem: a formula a user discontinues due to irritation provides no benefit regardless of its stability profile. The optimal pH range for both efficacy and stability is a narrow window, and it has to be maintained throughout the product's shelf life, not just at the time of manufacture.

Can vitamin C serum work if it's formulated at lower concentrations like 10% or 15%?

Concentrations in that range can still deliver meaningful antioxidant activity, and I won't dismiss them categorically. What I will say is that the pharmacokinetic advantages shift as concentration decreases: the solution's inherent buffering capacity is lower, the margin for degradation before efficacy drops below a useful threshold is narrower, and the formulator has less room for error in every other stability variable. From my experience, 20% is the concentration at which the formulation equation becomes most favorable for both potency and stability, which is why that's where I've landed in my own work.

The science of L-ascorbic acid stability is genuinely complex — more complex than most brand communication acknowledges — and getting it right requires treating every variable simultaneously, not sequentially. At Phyto-C, that's exactly how I've built every formula in the vitamin C line, and I invite you to examine the results directly.